Filing Details
- Accession Number:
- 0001127602-12-018680
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-31 16:40:32
- Reporting Period:
- 2012-05-30
- Filing Date:
- 2012-05-31
- Accepted Time:
- 2012-05-31 16:40:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1022079 | Quest Diagnostics Inc | DGX | Services-Medical Laboratories (8071) | 161387862 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1222674 | B John Ziegler | C/O Quest Diagnostics Incorporated 3 Giralda Farms Madison NJ 07940 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-05-30 | 382 | $28.42 | 21,036 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2012-05-30 | 482 | $30.28 | 21,518 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-05-30 | 864 | $58.13 | 20,654 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2012-05-30 | 382 | $0.00 | 382 | $28.42 |
Common Stock | Stock Options (Right to Buy) | Disposition | 2012-05-30 | 482 | $0.00 | 482 | $30.28 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2003-01-01 | 2013-01-01 | No | 4 | M | Direct |
0 | 2003-04-01 | 2013-04-01 | No | 4 | M | Direct |
Footnotes
- The exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 15, 2012.